Selvin E, Coresh J, Brancati FL
Osmotic laxatives , particularly polyethylene glycol 3350 (MiraLAX), are generally recommended as first-line pharmacologic therapy
They are awaiting grant of a patent by the US Food and Drug Administration to be used for the treatment of melasma, freckles, lentigines and postinflammatory hyperpigmentation
Semaglutide reduces cardiovascular events in type 2 diabetes: a systematic review and meta-analysis highlighting enhanced benefits in chronic kidney disease
These factors may include high BMI at the start of the therapy, adherence to nutritional guidelines, presence or absence of exercise and the type of exercise used, and more
Prevention of posterior capsule opacification through intracapsular hydrogen peroxide or distilled water treatment in human donor tissue